Research programme: GABA receptor modulators - BiotronAlternative Names: Gabion project
Latest Information Update: 04 Feb 2011
At a glance
- Originator Biotron
- Mechanism of Action GABA modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Anaesthesia; Seizures
Most Recent Events
- 04 Feb 2011 No development reported for Seizures in Australia (unspecified route)
- 04 Feb 2011 No development reported for Anaesthesia in Australia (unspecified route)
- 28 Jun 2007 Early research in Seizures in Australia (unspecified route)